Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Herpes simplex and herpes zoster

Dermatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Eye or neurological involvement cannot wait

Eye pain, photophobia, visual change, ophthalmoplegia, meningism, altered consciousness, focal neurology or disseminated vesicles can indicate sight- or life-threatening herpesvirus disease.

Action: Arrange same-day ophthalmic or emergency specialist assessment and start indicated systemic antiviral treatment without awaiting lesion PCR in a high-risk presentation.

Synopsis

Differentiate recurrent herpes simplex from dermatomal zoster, recognise ocular, neurological and disseminated emergencies, sample appropriately and start time-sensitive antiviral treatment with renal and transmission safeguards.

  • HSV typically causes recurrent grouped painful vesicles or erosions at a mucocutaneous site; zoster causes unilateral dermatomal pain followed by vesicles that usually do not cross the midline.
  • Swab a fresh vesicle base for PCR when diagnosis is uncertain, disease is severe or genital, or the result changes infection-control or specialist decisions.
  • Herpes zoster ophthalmicus, eye pain, photophobia or visual change requires same-day ophthalmic assessment; a normal-looking eye does not cancel symptoms.
  • Offer oral antivirals within 72 hours of zoster rash onset to people aged 50 or older and to younger people with ophthalmic, non-truncal, moderate-to-severe or immunocompromised disease.
  • Consider treatment up to seven days after onset when new vesicles continue or complication risk is high.
  • Aciclovir for zoster is 800 mg five times daily for seven days; valaciclovir 1 g three times daily for seven days improves dosing convenience.
  • Adjust aciclovir and valaciclovir for renal impairment, maintain hydration and review nephrotoxic medicines or new confusion.
  • Keep lesions covered, avoid pregnant non-immune people, neonates and severely immunocompromised contacts, and exclude from susceptible-care settings while lesions remain weeping.

Key red flags

Ocular symptoms, Hutchinson sign, neurological deficit, meningism, disseminated lesions, eczema herpeticum, pregnancy near delivery with genital lesions, neonatal exposure or severe immunocompromise requires urgent specialist care.

Ophthalmic zoster

Forehead, upper-eyelid or nasal-tip vesicles with eye symptoms indicates trigeminal involvement and possible intraocular disease.

Ramsay Hunt syndrome

Severe ear pain, vesicles in ear or palate, ipsilateral facial palsy, vertigo or hearing change needs urgent ENT and specialist antiviral care.

Eczema herpeticum

Sudden monomorphic painful punched-out erosions over eczema with fever or malaise requires same-day systemic antiviral assessment.

Disseminated or neurological disease

Widespread vesicles, confusion, seizure, meningism, focal deficit or visceral symptoms in herpesvirus infection is an emergency.

Investigation priorities

01
Vesicle-base HSV and VZV PCRFirst step

Distinguish herpes viruses in atypical, severe, genital or immunocompromised presentations.

Management branches

Uncomplicated eligible zosterTreat early and control pain

A unilateral dermatomal eruption is within 72 hours and age, severity, site or host risk meets antiviral criteria.

  1. Check eye, ear, neurological and dissemination features, pregnancy, immunity, renal function and medicines.
  2. Start aciclovir 800 mg five times daily or valaciclovir 1 g three times daily for seven days with renal adjustment and hydration advice.
  3. Provide stepped analgesia, cover lesions and review new vesicles, eye symptoms, weakness or uncontrolled pain promptly.

Key medicines

Aciclovir tabletsFor herpes zoster take 800 mg orally five times daily at approximately four-hour intervals while awake for seven days.Reduce dose in renal impairment, maintain hydration, review neurotoxicity and nephrotoxic medicines, and use intravenous treatment for severe disseminated or neurological disease.
Valaciclovir tabletsFor herpes zoster take 1 g orally three times daily for seven days, adjusted for renal function.Check kidney function, hydration, age and neurological symptoms; high exposure can cause confusion, hallucinations or renal injury.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NHS shinglesRecognition, urgent sites, transmission and treatment timing.
  • British Association of Dermatologists herpes simplexHSV morphology, recurrence, complications and treatment.
  • Aciclovir 800 mg tablets SmPCZoster dose, renal modification and safety.
  • Valaciclovir 1 g tablets SmPCZoster regimen, renal dosing and adverse effects.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom